MINDACT: adjuvant chemotherapy in breast cancer Published 2020-05-30 Download video MP4 360p Recommendations 04:48 Neoadjuvant Chemotherapy for Invasive Lobular Breast Cancer 07:08 What's the Best Diet for Hormone Receptor-Positive Breast Cancer? The Ultimate Guide 26:08 Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference 09:38 Starting Chemo and What You NEED to Know... (UPDATE) 02:38 Safety outcomes of darolutamide vs apalutamide and enzalutamide in nmCRPC 46:31 Adjuvant Therapy | 2023 Best of Breast Conference 03:13 Local breast cancer survivor shares nutrition tips that helped her heal 17:12 Odcinek 110. Jak wygląda dzień podania chemioterapii 02:30 ASCO 2024: Impact of Latino Ethnicity on Gut Microbiome in mRCC Regina Barragan-Carillo, Phd 24:10 Dr. Maryanne Demasi - 'Statin Wars: Have we been misled by the evidence?' 04:55 Aktualne trendy w leczeniu raka piersi 13:50 4 Tricks for when doctors gaslight you - Dr. Kaveh LIVE 16:52 Everything you need to know about Anastrazole and Letrozole || Dr Liz O'Riordan 1:01:23 Invasive Lobular Breast Cancer: A Different Disease 00:59 CheckMate 8HW: HRQoL outcomes of nivolumab and ipilimumab in MSI-H/dMMR mCRC 02:39 Jak wygląda leczenie wczesnego HER2+ raka piersi? 03:41 Adjuvant Breast Cancer Therapy 18:47 Regan's treatment story: Lemtrada 02:59 Chemotherapy Type and Sequence Can Impact Hair Retention in Breast Cancer 01:19 Optimizing adjuvant therapy: chemotherapy necessity in HR-positive breast cancer Similar videos 03:48 Adjuvant Therapy For Breast Cancer - Mayo Clinic 02:46 Adjuvant chemotherapy for breast cancer: who needs it? 09:35 MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in br... 02:02 Chemotherapy With Adjuvant Therapy in Breast Cancer 01:59 Dr. Melisko Reflects on Findings From the MINDACT Trial in Breast Cancer 22:48 Adjuvant Therapy of Breast Cancer 04:13 Genomic predictors for treatment selection in ER+ breast cancer: TAILORx, MINDACT, and RxPONDER 03:56 Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT 05:14 Adjuvant chemo omission feasible for certain postmenopausal breast cancer patients | Kevin Kalinsky 02:49 PROCURE: Genomic signatures and adjuvant chemotherapy for breast cancer in Europe 07:25 Results of the MINDACT clinical trial 01:09 Dr. Piccart on the MINDACT Study for Early-Stage Breast Cancer 09:51 MINDACT Trial Design and Results in Breast Cancer 02:20 Escalation of adjuvant therapy in HR+ breast cancer 06:41 Practice-Changing Results from the MINDACT Trial 01:56 Optimizing adjuvant treatment in HR+/HER2- early breast cancer 1:11:28 Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy 08:20 Updated findings on low-risk MINDACT participants reported | Laura van 't Veer More results